Literature DB >> 24731659

Adipokines in gestational diabetes.

Mathias Fasshauer1, Matthias Blüher2, Michael Stumvoll3.   

Abstract

Gestational diabetes is characterised by glucose intolerance with onset or first recognition during pregnancy. The disease shows facets of the metabolic syndrome including obesity, insulin resistance, and dyslipidaemia. Adipokines are a group of proteins secreted from adipocytes, which are dysregulated in obesity and contribute to metabolic and vascular complications. Recent studies have assessed the role of various adipokines including leptin, adiponectin, tumour necrosis factor α (TNFα), adipocyte fatty acid-binding protein (AFABP), retinol-binding protein 4 (RBP4), resistin, NAMPT, SERPINA12, chemerin, progranulin, FGF-21, TIMP1, LCN2, AZGP1, apelin (APLN), and omentin in gestational diabetes. This Review provides an overview of these key adipokines, their regulation in, and potential contribution to gestational diabetes. Based on the evidence so far, the adipokines adiponectin, leptin, TNFα, and AFABP seem to be the most probable candidates involved in the pathophysiology of gestational diabetes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24731659     DOI: 10.1016/S2213-8587(13)70176-1

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  66 in total

1.  The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.

Authors:  Ming-Ling Chang; Chia-Jung Kuo; Li-Heng Pao; Chen-Ming Hsu; Cheng-Tang Chiu
Journal:  Virulence       Date:  2017-03-07       Impact factor: 5.882

Review 2.  Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review.

Authors:  Wei Bao; Aileen Baecker; Yiqing Song; Michele Kiely; Simin Liu; Cuilin Zhang
Journal:  Metabolism       Date:  2015-01-29       Impact factor: 8.694

Review 3.  Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application.

Authors:  Christos Bikis; Theodora Tzanavari; Krystallenia I Alexandraki; Stamatios Theocharis
Journal:  Horm Cancer       Date:  2018-02-20       Impact factor: 3.869

4.  A longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period.

Authors:  Stefanie N Hinkle; Germaine M Buck Louis; Shristi Rawal; Yeyi Zhu; Paul S Albert; Cuilin Zhang
Journal:  Diabetologia       Date:  2016-09-19       Impact factor: 10.122

5.  Adipose Tissue Inflammation and Adrenomedullin Overexpression Contribute to Lipid Dysregulation in Diabetic Pregnancies.

Authors:  Yuanlin Dong; Madhu Chauhan; Ancizar Betancourt; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

6.  Are adipokines associated with gestational diabetes mellitus?

Authors:  Ümit Görkem; Ferit Kerim Küçükler; Cihan Toğrul; Tayfun Güngör
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

Review 7.  Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus.

Authors:  Camille E Powe
Journal:  Curr Diab Rep       Date:  2017-02       Impact factor: 4.810

Review 8.  Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Authors:  Gian Franco Adami; Nicola Scopinaro; Renzo Cordera
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

9.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

10.  SERUM IRISIN LEVEL INCREASES THROUGHOUT THE GESTATIONAL PERIOD AND IT DOES NOT PLAY A ROLE IN DEVELOPMENT OF GESTATIONAL DIABETES MELLITUS.

Authors:  S Sancak; H Aydın; M Sargin; A Orçun; A Özdemir; A Çelik; B Sunar; G Aslan
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.